Pharmacist Suspended for Illegally Supplying Prescription-Only Malaria Medicines from Home Address

Date of Decision: April 12, 2019

Registrant's Role: Pharmacist

Allegations:

• Sold and supplied prescription-only medications without valid prescriptions.
• Prescriptions lacked an advanced electronic signature and the address of the prescribing doctor.
• Entered into an agreement to receive and supply malaria medications via email from outside the UK.
• Dispensed and supplied medications from his home address rather than a registered pharmacy.
• Acted dishonestly by misleading patients and associates about the origin and legality of the medicines.

Outcome: Further suspension of registration for four months, with a review before expiry.

GPhC Standards Breached:

• Standard 1 – Provide person-centred care
• Standard 2 – Work in partnership with people
• Standard 3 – Communicate effectively
• Standard 6 – Behave professionally
• Standard 7 – Respect and maintain a person’s confidentiality and privacy
• Standard 9 – Demonstrate leadership

Case Summary

Allegations
This case revolves around a pharmacist who engaged in a pattern of misconduct that included the illegal sale and supply of prescription-only medicines (POMs), namely anti-malarial medications such as Doxycycline and Malarone. The misconduct occurred between October 2013 and April 2014. The pharmacist admitted to receiving prescriptions by email from a non-UK clinic and supplying the medication directly from his home address, bypassing the legal requirements for dispensing from registered premises. The prescriptions were found to be invalid as they lacked advanced electronic signatures and the prescribing doctor’s address, in breach of the Human Medicines Regulations 2012.

Furthermore, the pharmacist misrepresented the origin of the medications, misleading both the overseas clinic and the patients by attaching labels suggesting the drugs were dispensed from a licensed UK pharmacy. He also used email addresses and branding associated with his previous place of employment, deepening the deception. The financial gain was not insignificant—records showed over £23,000 in invoices related to these activities.

Findings
The Fitness to Practise Committee found the registrant’s actions constituted serious misconduct. Not only had he operated outside the legal framework for dispensing medications, but he also acted dishonestly by concealing the true nature of the dispensing arrangement. The panel found inconsistencies in his testimony, with conflicting statements made to police and the Committee about the source of the medications and the extent of his operations.

While the pharmacist initially denied a profit motive, claiming minimal financial returns, the evidence—including spreadsheets and statements from the clinic—demonstrated otherwise. The Committee considered the registrant’s assertions implausible and indicative of a lack of candour.

“The Committee does not consider that the business model which the Registrant described to us (i.e. making a very small amount of profit from the postage and packaging) is plausible… The Committee does not consider it likely that he would have spent so much time and effort for such little reward.”

GPhC Determination on Impairment
The panel found that the pharmacist’s fitness to practise remained impaired, primarily due to the serious nature of the misconduct, the proven dishonesty, and the registrant’s limited insight into the impact of his actions. Although the pharmacist had practiced without issue since 2014 and had undertaken CPD and volunteer work, the panel was unconvinced that he had fully grasped the implications of his behavior on patients, public trust, and the profession.

Despite some acknowledgment of wrongdoing and signs of remorse, the Committee noted that the registrant was still focusing heavily on the personal consequences rather than reflecting meaningfully on patient safety or professional standards.

Sanction
The Committee opted for a further suspension of four months, recognizing that while some insight and remediation had been demonstrated, full rehabilitation was not yet achieved. A strike-off was deemed disproportionate at this stage, but the registrant was clearly informed that more substantial progress in demonstrating insight and understanding would be required at the next review.

They encouraged further reflection, engagement with peer mentoring, and the continuation of professional development. Evidence of how the pharmacist now understands the risks and broader impacts of his misconduct would be essential.

Key Learning Points for Pharmacy Professionals

1. Adherence to Legal Requirements: Prescription-only medications must be dispensed according to strict legal protocols. Dispensing from an unlicensed location without valid prescriptions not only breaches regulations but jeopardizes patient safety.
2. Transparency and Integrity: Pharmacists must maintain honesty in all professional dealings. Misleading stakeholders about the source and legality of medication is a serious breach of trust.
3. Importance of Full Insight: In fitness to practise matters, insight is critical. Acknowledging personal impact is not sufficient—professionals must demonstrate a clear understanding of how their actions affect patients and the reputation of the profession.
4. Documentation and Accountability: Maintaining accurate records and ensuring all processes are transparent is essential. Misuse of branding or email communications to simulate legitimacy can lead to severe disciplinary action.
5. Reflective Practice and Revalidation: Professionals facing regulatory scrutiny must engage in robust reflective practice, ideally guided by mentoring and supported by evidence of CPD. Remediation must be genuine and comprehensive.

This case underscores the GPhC’s commitment to upholding public trust in pharmacy professionals and the need for rigorous adherence to ethical and legal standards in all aspects of pharmacy practice.

Original Case Document

The full determination transcript is available to logged in users.

Log in or Register for free to access.